Eosinophil-induced neurotoxicity: The role of eosinophil cationic protein/RNase 3

Journal of Neuroimmunology

Volumn 227, Issue 1-2, 2010, Pages 60-70

  Navarro, Susanna ^a   Boix, Ester ^a   Cuchillo, Claudi M ^a   Nogués, M Victòria ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Apoptosis; Caspase activity; Eosinophil cationic protein; Membrane permeability; Neurotoxicity; Protein aggregation

Indexed keywords

CALCIUM ION; CASPASE 3; CASPASE 8; CASPASE 9; EOSINOPHIL CATIONIC PROTEIN; APOPTOSIS REGULATORY PROTEIN; NEUROTOXIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN NERVE CELL; CALCIUM CELL LEVEL; CELL MEMBRANE PERMEABILITY; CELL NUCLEUS; CELL STRUCTURE; CELL SURFACE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; EOSINOPHIL; GRANULE CELL; NERVE CELL CULTURE; NERVE CELL MEMBRANE; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; ANIMAL; CELL CULTURE; CELL DEATH; CEREBELLUM; COMPARATIVE STUDY; DOSE RESPONSE; ENZYMOLOGY; HUMAN; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY; TOXICITY;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELL DEATH; CELLS, CULTURED; CEREBELLUM; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILS; HUMANS; NEUROTOXINS; RATS;

EID: 77956647384     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.06.012     Document Type: Article

References (40)

1. Ackerman S.J., Bochner B.S. Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders. Immunol. Allergy Clin. N. Am. 2007, 27:357-375.
2. Allsopp T.E., McLuckie J., Kerr L.E., Macleod M., Sharkey J., Kelly J.S. Caspase 6 activity initiates caspase 3 activation in cerebellar granule cell apoptosis. Cell Death Differ. 2000, 7:984-993.
3. Annunziato L., Amoroso S., Pannaccione A., Cataldi M., Pignataro G., D'Alessio A., Sirabella R., Secondo A., Sibaud L., Di Renzo G.F. Apoptosis induced in neuronal cells by oxidative stress: role played by caspases and intracellular calcium ions. Toxicol. Lett. 2003, 139:125-133.
4. Balazs R., Jorgensen O.S., Hack N. N-methyl-d-aspartate promotes the survival of cerebellar granule cells in culture. Neuroscience 1988, 27:437-451.
5. Benito A., Vilanova M., Ribó M. Intracellular routing of cytotoxic pancreatic-type ribonucleases. Curr. Pharm. Biotechnol. 2008, 9:169-179.
6. Boix E., Leonidas D.D., Nikolovski Z., Nogués M.V., Cuchillo C.M., Acharya K.R. Crystal structure of eosinophil cationic protein at 2.4A resolution. Biochemistry 1999, 38:16794-16801.
7. Boix E., Nikolovski Z., Moiseyev G.P., Rosenberg H.F., Cuchillo C.M., Nogués M.V. Kinetic and product distribution analysis of human eosinophil cationic protein indicates a subsite arrangement that favors exonuclease-type activity. J. Biol. Chem. 1999, 274:15605-15614.
8. Carreras E., Boix E., Navarro S., Rosenberg H.F., Cuchillo C.M., Nogués M.V. Surface-exposed amino acids of eosinophil cationic protein play a critical role in the inhibition of mammalian cell proliferation. Mol. Cell. Biochem. 2005, 272:1-7.
9. Chan S.L., Mattson M.P. Caspase and calpain substrates: roles in synaptic plasticity and cell death. J. Neurosci. Res. 1999, 58:167-190.
10. Durack D.T., Ackerman S.J., Loegering D.A., Gleich G.J. Purification of human eosinophil-derived neurotoxin. Proc. Natl Acad. Sci. USA 1981, 78:5165-5169.
11. Fredens K., Dahl R., Venge P. The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X. J. Allergy Clin. Immunol. 1982, 70:361-366.
12. Giffard R.G., Swanson R.A. Ischemia-induced programmed cell death in astrocytes. Glia 2005, 50:299-306.
13. Gleich G.J., Leiferman K.M. The hypereosinophilic syndromes: current concepts and treatments. Br. J. Haematol. 2009, 145:271-285.
14. Hallgren R., Terent A., Venge P. Eosinophil cationic protein (ECP) in the cerebrospinal fluid. J. Neurol. Sci. 1983, 58:57-71.
15. Kawahara M., Kuroda Y. Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: channel formation and disruption of calcium homeostasis. Brain Res. Bull. 2000, 53:389-397.
16. Klion A. Hypereosinophilic syndrome: current approach to diagnosis and treatment. Annu. Rev. Med. 2009, 60:293-306.
17. Lee J.D., Chen S.T., Chen C.J., Chen C.M., Ro L.S. Idiopathic hypereosinophilic syndrome with eosinophilic myositis, peripheral neuropathy and central nervous system involvement. J. Formos. Med. Assoc. 1996, 95:933-936.
18. Lo Re V., Gluckman S.J. Eosinophilic meningitis. Am. J. Med. 2003, 114:217-223.
19. Maccioni R.B., Munoz J.P., Barbeito L. The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch. Med. Res. 2001, 32:367-381.
20. Maeda T., Kitazoe M., Tada H., de Llorens R., Salomon D.S., Ueda M., Yamada H., Seno M. Growth inhibition of mammalian cells by eosinophil cationic protein. Eur. J. Biochem. 2002, 269:307-316.
21. Marini A.M., Nowak T.S. Metabolic effects of 1-methyl-4-phenylpyridinium (MPP(+)) in primary neuron cultures. J. Neurosci. Res. 2000, 62:814-820.
22. Mattson M.P. Calcium and neurodegeneration. Aging Cell 2007, 6:337-350.
23. Mattson M.P., Culmsee C., Yu Z.F. Apoptotic and antiapoptotic mechanisms in stroke. Cell Tissue Res. 2000, 301:173-187.
24. Mayhan W.G. Leukocyte adherence contributes to disruption of the blood-brain barrier during activation of mast cells. Brain Res. 2000, 869:112-120.
25. Motojima S., Frigas E., Loegering D.A., Gleich G.J. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am. Rev. Respir. Dis. 1989, 139:801-805.
26. Navarro S., Aleu J., Jiménez M., Boix E., Cuchillo C.M., Nogués M.V. The cytotoxicity of eosinophil cationic protein/ribonuclease 3 on eukaryotic cell lines takes place through its aggregation on the cell membrane. Cell. Mol. Life Sci. 2008, 65:324-337.
27. Newton D.L., Walbridge S., Mikulski S.M., Ardelt W., Shogen K., Ackerman S.J., Rybak S.M., Youle R.J. Toxicity of an antitumor ribonuclease to Purkinje neurons. J. Neurosci. 1994, 14:538-544.
28. Nikolovski Z., Buzón V., Ribo M., Moussaoui M., Vilanova M., Cuchillo C.M., Cladera J., Nogués M.V. Thermal unfolding of eosinophil cationic protein/ribonuclease 3: a nonreversible process. Protein Sci. 2006, 15:2816-2827.
29. Peng J., Wu Z., Wu Y., Hsu M., Stevenson F.F., Boonplueang R., Roffler-Tarlov S.K., Andersen J.K. Inhibition of caspases protects cerebellar granule cells of the weaver mouse from apoptosis and improves behavioral phenotype. J. Biol. Chem. 2002, 277:44285-44291.
30. Pitto M., Parenti M., Guzzi F., Magni F., Palestini P., Ravasi D., Masserini M. Palmitic is the main fatty acid carried by lipids of detergent-resistant membrane fractions from neural and non-neural cells. Neurochem. Res. 2002, 27:729-734.
31. Plager D.A., Davis M.D., Andrews A.G., Coenen M.J., George T.J., Gleich G.J., Leiferman K.M. Eosinophil ribonucleases and their cutaneous lesion-forming activity. J. Immunol. 2009, 183:4013-4020.
32. Ribe E.M., Serrano-Saiz E., Akpan N., Troy C.M. Mechanisms of neuronal death in disease: defining the models and the players. Biochem. J. 2008, 415:165-182.
33. Saura J. Microglial cells in astroglial cultures: a cautionary note. J. Neuroinflammation 2007, 4:26.
34. Torrent M., Cuyás E., Carreras E., Navarro S., López O., de la Maza A., Nogués M.V., Reshetnyak Y.K., Boix E. Topography studies on the membrane interaction mechanism of the eosinophil cationic protein. Biochemistry 2007, 46:720-733.
35. Torrent M., Navarro S., Moussaoui M., Nogués M.V., Boix E. Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans. Biochemistry 2008, 47:3544-3555.
36. Torrent M., Sánchez D., Buzón V., Nogués M.V., Cladera J., Boix E. Comparison of the membrane interaction mechanism of two antimicrobial RNases: RNase 3/ECP and RNase 7. Biochim. Biophys. Acta 2009, 1788:1116-1125.
37. Trulson A., Bystrom J., Engstrom A., Larsson R., Venge P. The functional heterogeneity of eosinophil cationic protein is determined by a gene polymorphism and post-translational modifications. Clin. Exp. Allergy 2007, 37:208-218.
38. Vetri V., Carrotta R., Picone P., Di Carlo M., Militello V. Concanavalin A aggregation and toxicity on cell cultures. Biochim. Biophys. Acta 2010, 1804:173-183.
39. Weaver D.F., Heffernan L.P., Purdy R.A., Ing V.W. Eosinophil-induced neurotoxicity: axonal neuropathy, cerebral infarction, and dementia. Neurology 1988, 38:144-146.
40. Woschnagg C., Rubin J., Venge P. Eosinophil cationic protein (ECP) is processed during secretion. J. Immunol. 2009, 183:3949-3954.